Physical inactivity exacerbates pathologic inflammatory signalling at the single cell level in patients with systemic lupus
This work was supported by the US National Institutes of Health (NIH) (R01 AR069616, K23HL138461-01A1, K23AT011768) the US CDC (U01DP0670), and the CZ Biohub.
Authors
- Charles Langelier (ORCID: https://orcid.org/0000-0002-6708-4646)
- Chun Jimmie Ye (ORCID: https://orcid.org/0000-0001-6560-3783)
- Kamil E. Barbour (ORCID: https://orcid.org/0000-0003-0546-6742)
- Joon‐Suk Park (ORCID: https://orcid.org/0000-0002-1182-4836)
- Jinoos Yazdany (ORCID: https://orcid.org/0000-0002-3508-4094)
- Cristina Lanata (ORCID: https://orcid.org/0000-0002-6017-4921)
- Maria Dall’Era (ORCID: https://orcid.org/0000-0001-7439-2316)
- Hoang Van Phan (ORCID: https://orcid.org/0000-0002-0162-4283)
- Sarah L. Patterson (ORCID: https://orcid.org/0000-0002-6661-019X)
- Patricia Katz
- Sebastián Cruz-González (ORCID: https://orcid.org/0000-0001-6505-0429)
- Lindsey A. Criswell (ORCID: https://orcid.org/0000-0002-0761-7543)
- Marina Sirota (ORCID: https://orcid.org/0000-0002-7246-6083)
Institutions
- Centers for Disease Control and Prevention (US)
- University of California, San Francisco (US)
- National Human Genome Research Institute (US)
- Cancer Research And Biostatistics (US)
- Chan Zuckerberg Initiative (United States) (US)
Publication Details
- Journal
- EBioMedicine
- Published
- 2024-11-11
- DOI
- https://doi.org/10.1016/j.ebiom.2024.105432
- Citations
- 4
- Primary Topic
- Systemic Lupus Erythematosus Research
- Type
- article
- Field-Weighted Citation Impact
- 1.88
Funders
- Amgen
- Pfizer
- Northwestern University
- Lupus Research Alliance
- Parker Institute for Cancer Immunotherapy
- Maze Therapeutics
- Yonsei University
- Renji Hospital
- National Institutes of Health
- Centers for Disease Control and Prevention
- Genentech
- University of California, San Francisco
- Yonsei University College of Medicine
- National Institute of Arthritis and Musculoskeletal and Skin Diseases